Drug treats rare heart disease by silencing gene
A Phase 3 clinical trial of the investigational drug vutrisiran has shown that it can reduce the risk of death and recurring cardiovascular events in people with a specific heart condition...
A Phase 3 clinical trial of the investigational drug vutrisiran has shown that it can reduce the risk of death and recurring cardiovascular events in people with a specific heart condition...
The genetic background of a new blood group system has been identified, solving a 50-year-old mystery...
by Blair Sowry
Republican senators in the USA have voted against a bill which aimed to allow greater access to IVF treatment across the country...
Eight percent of UK adults have the same risk of heart disease due to cumulative polygenic changes as carriers of a single rare mutation, according to a study...
Over 3000 genetic variants could disrupt normal function of the RAD51C breast and ovarian cancer gene...
by Jake Knox
No clear evidence has been found of increased risk of neurodevelopmental disorders in children born to men taking anti-seizure medication, in a systemic review...
by Éilis Mathur
A chilling story of a man who is purported to have fathered up to 1000 children through sperm donation...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.
Comment
Ban the use of genomic data by UK insurers
by Harry Farmer
Drawing from the report 'Predicting: The Future of Health?', from the Ada Lovelace Institute and the Nuffield Council on Bioethics, senior researcher Harry Farmer explains why it's time for a real ban on the use of genomic data by UK insurers...